We are live on ! Find out more
LCM

Legato Capital Management Portfolio holdings

AUM $1.21B
1-Year Est. Return 82.36%
This Fund
S&P 500
This Quarter Est. Return
+16.16%
1 Year Est. Return
+82.36%
3 Year Est. Return
+243.02%
5 Year Est. Return
+342.37%
10 Year Est. Return
+764.01%
AUM
$918M
AUM Growth
+$78.7M
Cap. Flow
-$9.19M
Cap. Flow %
-1%
Top 10 Hldgs %
12.06%
Holding
631
New
69
Increased
135
Reduced
112
Closed
73

Top Buys

Rank Stock Value
1
VC icon
Visteon
VC
+$2.62M
2
SYM icon
Symbotic
SYM
+$2.58M
3
CLMB icon
Climb Global Solutions
CLMB
+$2.58M
4
ADBE icon
Adobe
ADBE
+$1.81M
5
ROAD icon
Construction Partners
ROAD
+$1.77M

Top Sells

Rank Stock Value
1
AVGO icon
Broadcom
AVGO
+$3.62M
2
VRNA
Verona Pharma
VRNA
+$3.24M
3
SHO icon
Sunstone Hotel Investors
SHO
+$2.69M
4
BAC icon
Bank of America
BAC
+$2.21M
5
AMGN icon
Amgen
AMGN
+$2.19M

Sector Composition

Rank Sector Weight
1 Technology 27.75%
2 Industrials 21.67%
3 Healthcare 15.84%
4 Consumer Discretionary 10.72%
5 Financials 10.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EGAN icon
501
eGain
EGAN
$202M
$245K 0.03%
28,152
HTFL
502
Heartflow Inc
HTFL
$2.58B
$243K 0.03%
+7,215
New +$232K
III icon
503
Information Services Group
III
$252M
$241K 0.03%
41,973
-6,191
-13% -$30.8K
CRNX icon
504
Crinetics Pharmaceuticals
CRNX
$8.94B
$237K 0.03%
+5,685
New +$182K
STUB
505
StubHub Holdings
STUB
$3.35B
$232K 0.03%
+13,759
New +$252K
DGII icon
506
Digi International
DGII
$3.15B
$225K 0.02%
6,160
AVAH icon
507
Aveanna Healthcare
AVAH
$2.05B
$218K 0.02%
24,622
ABVX
508
Abivax
ABVX
$11.1B
$217K 0.02%
+2,554
New +$157K
TCBX icon
509
Third Coast Bancshares
TCBX
$731M
$217K 0.02%
5,703
-794
-12% -$30.1K
NGVT icon
510
Ingevity
NGVT
$2.63B
$215K 0.02%
+3,888
New +$202K
VRDN icon
511
Viridian Therapeutics
VRDN
$2.61B
$211K 0.02%
+9,796
New +$177K
NATH icon
512
Nathan's Famous
NATH
$402M
$210K 0.02%
1,897
MTN icon
513
Vail Resorts
MTN
$5.23B
$206K 0.02%
+1,379
New +$214K
RDWR icon
514
Radware
RDWR
$1.2B
$205K 0.02%
7,731
-398
-5% -$10.6K
ITRN icon
515
Ituran Location and Control
ITRN
$1.03B
$204K 0.02%
5,698
+443
+8% +$16.7K
EVLV icon
516
Evolv Technologies
EVLV
$1.06B
$203K 0.02%
+26,850
New +$196K
UAMY icon
517
United States Antimony
UAMY
$1.01B
$199K 0.02%
+32,165
New +$134K
NEXN
518
Nexxen International
NEXN
$588M
$187K 0.02%
20,213
+7,124
+54% +$70.7K
HDSN
519
Hudson Technologies
HDSN
$241M
$183K 0.02%
18,479
ACEL icon
520
Accel Entertainment
ACEL
$978M
$177K 0.02%
16,033
BCRX icon
521
BioCryst Pharmaceuticals
BCRX
$2.45B
$165K 0.02%
21,777
CRD.A icon
522
Crawford & Co Class A
CRD.A
$637M
$165K 0.02%
15,436
RLGT icon
523
Radiant Logistics
RLGT
$392M
$159K 0.02%
26,901
WNEB icon
524
Western New England Bancorp
WNEB
$272M
$156K 0.02%
13,027
NPKI
525
NPK International
NPKI
$1.14B
$127K 0.01%
11,243

Similar funds

Legato Capital Management's Q3 2025 Portfolio in Review

As of Q3 2025, Legato Capital Management held 631 positions worth $918M, up 9.4% from $839M the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Legato Capital Management's Q3 2025 filing shows 69 new, 135 increased, 112 reduced and 73 closed positions. Its largest new stake was Visteon: 22,225 shares worth $2.66M. The largest sale was Broadcom, an estimated $3.62M.

By sector, the portfolio is most concentrated in Technology at 28% of assets, down from 28% a quarter earlier, followed by Industrials and Healthcare.

  • Legato Capital Management's largest Q3 2025 buy was Visteon: 22,225 shares worth $2.66M.
  • Legato Capital Management added most to Construction Partners in Q3 2025, an estimated $1.77M increase.
  • Legato Capital Management's biggest Q3 2025 reduction was Broadcom, cutting an estimated $3.62M.
  • Legato Capital Management fully exited Verona Pharma in Q3 2025, selling an estimated $3.24M.
  • Legato Capital Management's ten largest holdings make up 12% of its $918M portfolio in Q3 2025.
  • Legato Capital Management opened 69 new positions and closed 73 in Q3 2025.
  • Legato Capital Management's portfolio value rose 9.4% quarter-over-quarter to $918M.

Based on Legato Capital Management's 13F filing for Q3 2025, filed 12 Nov 2025.